23/10/2026
🔥 2026 TAAB Annual Symposium|Virtual / Live Stream Available
🌎 無法親臨費城?今年 TAAB 年會也能線上參與!
從新一代細胞治療、液態切片、真實世界證據(RWE),到 AI 如何改變人才招募、科學家如何邁向領導角色,以及台美生技產業的跨國合作,今年 TAAB 年會的精彩內容,不只限於現場!
今年年會特別開放 6 場精彩議程線上直播,包含兩場 Keynote Talks、兩場 Featured Speeches,以及聚焦職涯領導與台美生技合作的兩場深度對談。
無論你身在美國其他城市、台灣,或世界各地,都歡迎透過線上參與,一起掌握生技產業的新趨勢與職涯發展的多元可能!
🎤 Keynote Talks|主題演講
1️⃣ In vivo CAR-T: From Bench to Bedside
從創新技術到臨床轉譯,探索 in vivo CAR-T 如何開創細胞治療的新可能。
Haig Aghajanian, Ph.D.
Founder, Capstan Therapeutics
Adjunct Assistant Professor of Medicine, University of Pennsylvania
https://www.linkedin.com/in/haig-aghajanian-4157b14/
2️⃣ AI Can Write Your CV. But Can It Get You Hired?
當 AI 已經能幫你寫履歷,真正決定職涯競爭力的又是什麼?從產業領導者的視角,重新思考 AI 時代的求職策略。
Russell Weiner, Ph.D., FAAPS
VP/Head of Translational Sciences, Alexion Pharmaceuticals
Immediate Past President, AAPS
https://www.linkedin.com/in/russellweiner/
🔬 Featured Speeches|專題演講
3️⃣ Liquid Biopsy: Making Molecular Diagnosis Accessible to Patients
液態切片如何推動分子診斷技術的發展,讓精準醫療更貼近患者的實際需求?
Hsian-Rong Tseng, Ph.D.
Professor of Molecular & Medical Pharmacology, UCLA
https://www.linkedin.com/in/hrtseng/
4️⃣ Real-World Evidence: Transforming Drug Development, Accelerating Approval, and Powering Market Access
真實世界證據如何影響新藥研發、法規審查與市場准入,成為生技醫藥產業的重要決策工具?
Chi-Chang Chen, Ph.D.
Senior Principal, US Real-World Solutions and Outcomes Research, IQVIA
https://www.linkedin.com/in/chichangchen/
🚀 Panel Discussion|科學家到領導者的轉型
5️⃣ Leveling Up: The Leap from Scientist to Leader
從科學專業走向團隊領導,需要哪些不同的能力與思維?三位來自學術界、生技醫藥產業與法規領域的資深領袖,分享跨越職涯階段的經驗與挑戰。
🎙️ Panelists
Sheng-Han Kuo, M.D.
H. Houston Merritt Associate Professor of Neurology, Columbia University
https://www.linkedin.com/in/sheng-han-kuo-42264816/
Gary K.H. Huang, M.D., Ph.D., M.Sc., FAAAAI
Executive Medical Director, Johnson & Johnson Innovative Medicine
https://www.linkedin.com/in/garykhhuang/
Hsiao-Ling Hung, Ph.D., RAC
President, TAAB
Biopharmaceutical Regulatory & Drug Development Leader
Former SVP, Ambrx Biopharma
https://www.linkedin.com/in/hsiao-ling-hung-phd-rac-7771113/
🤝 US × Taiwan Fireside Chat|台美生技跨國對談
6️⃣ Taiwanese Talent, Global Impact: Bridging US–Taiwan Biotech
台灣生技人才如何在國際舞台發揮影響力?台美雙方又該如何整合人才、技術與產業資源,開拓跨國合作的新契機?本場將串聯台灣與美國的生技產業領袖,從創業、商業開發、創新技術與產業發展等不同視角,探討台美生技合作的未來。
🎙️ Panelists
Richard Liang, Ph.D.
Chief Technology Officer, Graphen
https://www.linkedin.com/in/richardliangphd/
Sarah Tsao, Ph.D.
Director of Business Development, Taiwan CDMO Alliance
https://www.linkedin.com/in/sarahtsao/
Sonny Hsiao, Ph.D.
Founder and CEO, Acepodia
https://www.linkedin.com/in/sonny-hsiao-83199956/
Tsai-Kun Li, Ph.D.
President, Development Center for Biotechnology (DCB)
Professor, National Taiwan University
https://www.dcb.org.tw/members/22?locale=en
📅 November 7–8, 2026
🔗 年會資訊與報名:https://www.taab-us.org/2026-taab-symposium/
不論你身在何處,都歡迎加入今年的 TAAB Annual Symposium,與我們一起探索生技創新、交流產業觀點、拓展職涯視野!
線上直播限上述指定場次,非年會所有活動皆提供直播。
---------------------------------------------
🔥 2026 TAAB Annual Symposium|Virtual / Live Stream Available
🌎 Can't make it to Philadelphia? Join us virtually!
Biotech innovation and career opportunities know no boundaries—and neither should the conversations that shape their future.
This year's TAAB Annual Symposium will offer live streaming for six featured sessions, bringing together leading scientists, biotech executives, and industry professionals to share insights on emerging technologies, career development, leadership, and cross-border collaboration.
Whether you're tuning in from another U.S. city, Taiwan, or anywhere around the world, don't miss the opportunity to be part of these conversations!
🎤 KEYNOTE TALKS
1️⃣ In vivo CAR-T: From Bench to Bedside
Explore how in vivo CAR-T technology is opening new possibilities for cell therapy and clinical translation.
Haig Aghajanian, Ph.D.
Founder, Capstan Therapeutics
Adjunct Assistant Professor of Medicine, University of Pennsylvania
https://www.linkedin.com/in/haig-aghajanian-4157b14/
2️⃣ AI Can Write Your CV. But Can It Get You Hired?
As AI transforms the job search, what does it really take to stand out and build a successful career?
Russell Weiner, Ph.D., FAAPS
VP/Head of Translational Sciences, Alexion Pharmaceuticals
Immediate Past President, AAPS
https://www.linkedin.com/in/russellweiner/
🔬 FEATURED SPEECHES
3️⃣ Liquid Biopsy: Making Molecular Diagnosis Accessible to Patients
Discover advances in liquid biopsy and their potential to make molecular diagnostics more accessible.
Hsian-Rong Tseng, Ph.D.
Professor of Molecular & Medical Pharmacology, UCLA
https://www.linkedin.com/in/hrtseng/
4️⃣ Real-World Evidence: Transforming Drug Development, Accelerating Approval, and Powering Market Access
Learn how real-world evidence is shaping drug development, regulatory decisions, and market access.
Chi-Chang Chen, Ph.D.
Senior Principal, US Real-World Solutions and Outcomes Research, IQVIA
https://www.linkedin.com/in/chichangchen/
🚀 PANEL DISCUSSION
5️⃣ Leveling Up: The Leap from Scientist to Leader
What does it take to move beyond scientific expertise and become an effective leader? Hear from experienced leaders across academia, biopharma, and regulatory affairs as they share their career journeys and leadership perspectives.
🎙️ Panelists
Sheng-Han Kuo, M.D.
H. Houston Merritt Associate Professor of Neurology, Columbia University
https://www.linkedin.com/in/sheng-han-kuo-42264816/
Gary K.H. Huang, M.D., Ph.D., M.Sc., FAAAAI
Executive Medical Director, Johnson & Johnson Innovative Medicine
https://www.linkedin.com/in/garykhhuang/
Hsiao-Ling Hung, Ph.D., RAC
President, TAAB
Biopharmaceutical Regulatory & Drug Development Leader
Former SVP, Ambrx Biopharma
https://www.linkedin.com/in/hsiao-ling-hung-phd-rac-7771113/
🤝 US × TAIWAN FIRESIDE CHAT
6️⃣ Taiwanese Talent, Global Impact: Bridging US–Taiwan Biotech
How can Taiwanese biotech talent create a greater global impact? What opportunities exist to strengthen collaboration between the U.S. and Taiwan? Join four industry leaders for a cross-border conversation on biotechnology innovation, entrepreneurship, business development, and opportunities for international partnerships.
🎙️ Panelists
Richard Liang, Ph.D.
Chief Technology Officer, Graphen
https://www.linkedin.com/in/richardliangphd/
Sarah Tsao, Ph.D.
Director of Business Development, Taiwan CDMO Alliance
https://www.linkedin.com/in/sarahtsao/
Sonny Hsiao, Ph.D.
Founder and CEO, Acepodia
https://www.linkedin.com/in/sonny-hsiao-83199956/
Tsai-Kun Li, Ph.D.
President, Development Center for Biotechnology (DCB)
Professor, National Taiwan University
https://www.dcb.org.tw/members/22?locale=en
📅 November 7–8, 2026
📍 University of Pennsylvania, Philadelphia | Online
🔗 Event Details & Registration:
https://www.taab-us.org/2026-taab-symposium/
Wherever you are, join us to explore what's next in biotechnology, connect with new perspectives, and discover opportunities for professional growth.
Live streaming is available for the six sessions listed above, not the entire symposium program.